ArriVent BioPharma (AVBP) Times Interest Earned (2023 - 2026)
ArriVent BioPharma (AVBP) reported Times Interest Earned of -$1.15 for Q1 2026, up 49.09% on a YoY basis from -$0.77 in Q1 2025, and up 99.5% sequentially from -$231.09 in Q4 2025.
ArriVent BioPharma (AVBP) Times Interest Earned (2023 - 2026) Analysis & Trends
ArriVent BioPharma (AVBP) has 4 years of Times Interest Earned data on file, last reported at -$1.15 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 49.09% year-over-year to -$1.15; the trailing twelve-month figure through Mar 2026 stood at -$3.92 (up 17.64% YoY), and the FY2025 full-year result was -$5.6, down 199.25% from the prior year.
- Times Interest Earned grew to -$1.15 in Q1 2026, from -$231.09 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.52 in Q4 2023 to a low of -$231.09 in Q4 2025.
- A 4-year average of -$33.84 and a median of -$1.03 in 2026 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned sank 18829.84% in 2024 and soared 49.09% in 2026, its largest moves.
- Tracing AVBP's Times Interest Earned over 4 years: stood at -$0.52 in 2023, then slumped by 18829.84% to -$99.18 in 2024, then slumped by 132.99% to -$231.09 in 2025, then soared by 99.5% to -$1.15 in 2026.
- Business Quant data shows AVBP's Times Interest Earned at -$1.15 in Q1 2026, -$231.09 in Q4 2025, and -$1.35 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - | -1.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.15 |
| Dec 31, 2025 | -231.09 |
| Sep 30, 2025 | -1.35 |
| Jun 30, 2025 | -0.91 |
| Mar 31, 2025 | -2.26 |
| Dec 31, 2024 | -99.18 |
| Sep 30, 2024 | -0.57 |
| Jun 30, 2024 | -0.78 |
| Mar 31, 2024 | -0.63 |
| Dec 31, 2023 | -0.52 |